BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7756338)

  • 1. Fusion of cationic liposomes with mammalian cells occurs after endocytosis.
    Wrobel I; Collins D
    Biochim Biophys Acta; 1995 May; 1235(2):296-304. PubMed ID: 7756338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusogenic activity of cationic lipids and lipid shape distribution.
    Lonez C; Lensink MF; Kleiren E; Vanderwinden JM; Ruysschaert JM; Vandenbranden M
    Cell Mol Life Sci; 2010 Feb; 67(3):483-94. PubMed ID: 19924382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular Distribution of Lipids and Encapsulated Model Drugs from Cationic Liposomes with Different Uptake Pathways.
    Takikawa M; Fujisawa M; Yoshino K; Takeoka S
    Int J Nanomedicine; 2020; 15():8401-8409. PubMed ID: 33149583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering osteogenic microenvironments by combination of multilayers from collagen type I and chondroitin sulfate with novel cationic liposomes.
    Brito Barrera YA; Hause G; Menzel M; Schmelzer CEH; Lehner E; Mäder K; Wölk C; Groth T
    Mater Today Bio; 2020 Jun; 7():100071. PubMed ID: 32924006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusogenic liposomes encapsulating mitochondria as a promising delivery system for osteoarthritis therapy.
    Kim HR; Cho HB; Lee S; Park JI; Kim HJ; Park KH
    Biomaterials; 2023 Nov; 302():122350. PubMed ID: 37864947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo.
    Kong H; Zheng C; Yi K; Mintz RL; Lao YH; Tao Y; Li M
    Nat Commun; 2024 May; 15(1):4267. PubMed ID: 38769317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-Targeted Lipid Nanoparticles Loaded with Rotenone as a New Approach for the Treatment of Oncological Diseases.
    Vasileva L; Gaynanova G; Kuznetsova D; Valeeva F; Lyubina A; Amerhanova S; Voloshina A; Sibgatullina G; Samigullin D; Petrov K; Zakharova L
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications.
    Shtykalova S; Deviatkin D; Freund S; Egorova A; Kiselev A
    Life (Basel); 2023 Mar; 13(4):. PubMed ID: 37109432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review.
    Abbasi H; Kouchak M; Mirveis Z; Hajipour F; Khodarahmi M; Rahbar N; Handali S
    Adv Pharm Bull; 2023 Jan; 13(1):7-23. PubMed ID: 36721822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection-Enhanced Delivery of Antiangiogenic Drugs and Liposomal Cytotoxic Drugs to Heterogeneous Brain Tumor for Combination Therapy.
    Bhandari A; Jaiswal K; Singh A; Zhan W
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionic liquids: prospects for nucleic acid handling and delivery.
    Egorova KS; Posvyatenko AV; Larin SS; Ananikov VP
    Nucleic Acids Res; 2021 Feb; 49(3):1201-1234. PubMed ID: 33476366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-viral transfection vectors: are hybrid materials the way forward?
    Gigante A; Li M; Junghänel S; Hirschhäuser C; Knauer S; Schmuck C
    Medchemcomm; 2019 Oct; 10(10):1692-1718. PubMed ID: 32180915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief update on endocytosis of nanomedicines.
    Patel S; Kim J; Herrera M; Mukherjee A; Kabanov AV; Sahay G
    Adv Drug Deliv Rev; 2019 Apr; 144():90-111. PubMed ID: 31419450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors.
    Degors IMS; Wang C; Rehman ZU; Zuhorn IS
    Acc Chem Res; 2019 Jul; 52(7):1750-1760. PubMed ID: 31243966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen Priming with Enantiospecific Cationic Lipid Nanoparticles Induces Potent Antitumor CTL Responses through Novel Induction of a Type I IFN Response.
    Gandhapudi SK; Ward M; Bush JPC; Bedu-Addo F; Conn G; Woodward JG
    J Immunol; 2019 Jun; 202(12):3524-3536. PubMed ID: 31053626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipo-PEG-PEI complex as an intracellular transporter for protein therapeutics.
    Lin YL; Chen CH; Liu YK; Huang TH; Tsai NM; Tzou SC; Liao KW
    Int J Nanomedicine; 2019; 14():1119-1130. PubMed ID: 30863049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Hearing Loss and Gene Therapy.
    Carpena NT; Lee MY
    Genomics Inform; 2018 Dec; 16(4):e20. PubMed ID: 30602081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximity Ligation Assays for In Situ Detection of Innate Immune Activation: Focus on In Vitro-Transcribed mRNA.
    Blanchard EL; Loomis KH; Bhosle SM; Vanover D; Baumhof P; Pitard B; Zurla C; Santangelo PJ
    Mol Ther Nucleic Acids; 2019 Mar; 14():52-66. PubMed ID: 30579042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a Multicompartment Hydrogel that Facilitates Time-Resolved Delivery of Combination Therapy and Synergized Killing of Glioblastoma.
    Majumder P; Baxa U; Walsh STR; Schneider JP
    Angew Chem Int Ed Engl; 2018 Nov; 57(46):15040-15044. PubMed ID: 30240496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane insertion of-and membrane potential sensing by-semiconductor voltage nanosensors: Feasibility demonstration.
    Park K; Kuo Y; Shvadchak V; Ingargiola A; Dai X; Hsiung L; Kim W; Zhou H; Zou P; Levine AJ; Li J; Weiss S
    Sci Adv; 2018 Jan; 4(1):e1601453. PubMed ID: 29349292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.